2013-2028 Report on Global Biologics and Biosimilars Market by Player, Region, Type, Application and Sales Channel

Published: Jul, 2019 | Pages: 124 | Publisher: MAResearch
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)

The global Biologics and Biosimilars market was valued at $XX million in 2018, and MAResearch analysts predict the global market size will reach $XX million by the end of 2028, growing at a CAGR of XX% between 2018 and 2028.

This report provides detailed historical analysis of global market for Biologics and Biosimilars from 2013-2018, and provides extensive market forecasts from 2019-2028 by region/country and subsectors. It covers the sales volume, price, revenue, gross margin, historical growth and future perspectives in the Biologics and Biosimilars market.

Leading players of Biologics and Biosimilars including:

•	Roche
•	Amgen
•	AbbVie
•	Sanofi-Aventis
•	Johnson & Johnson
•	Pfizer
•	Novo Nordisk
•	Eli Lilly
•	Novartis
•	Merck
•	3sbio
•	Changchun High Tech
•	CP Guojian
•	Biotech
•	Gelgen
•	Innovent
•	Dong Bao
•	Ganlee

Market split by Type, can be divided into:

•	Monoclonal Antibodies
•	Interferon
•	Erythropoietin
•	Insulin
•	Vaccines
•	Other

Market split by Application, can be divided into:

•	Tumor
•	Diabetes
•	Cardiovascular
•	Hemophilia
•	Other

Market split by Sales Channel, can be divided into:

•	Direct Channel
•	Distribution Channel

Market segment by Region/Country including:

•	North America (United States, Canada and Mexico)
•	Europe (Germany, UK, France, Italy, Russia and Spain etc.)
•	Asia-Pacific (China, Japan, Korea, India, Australia and Southeast Asia etc.)
•	South America Brazil, Argentina, Colombia and Chile etc.)
•	Middle East & Africa (South Africa, Egypt, Nigeria and Saudi Arabia etc.)

If you have any special requirement, please let us know and we can provide you the report as your requirement.

 Table of Contents

Chapter 1 Biologics and Biosimilars Market Overview
    1.1 Biologics and Biosimilars Definition
    1.2 Global Biologics and Biosimilars Market Size Status and Outlook (2013-2028)
    1.3 Global Biologics and Biosimilars Market Size Comparison by Region (2013-2028)
    1.4 Global Biologics and Biosimilars Market Size Comparison by Type (2013-2028)
    1.5 Global Biologics and Biosimilars Market Size Comparison by Application (2013-2028)
    1.6 Global Biologics and Biosimilars Market Size Comparison by Sales Channel (2013-2028)
    1.7 Biologics and Biosimilars Market Dynamics
        1.7.1 Market Drivers/Opportunities
        1.7.2 Market Challenges/Risks
        1.7.3 Market News (Mergers/Acquisitions/ Expansion)

Chapter 2 Biologics and Biosimilars Market Segment Analysis by Player
    2.1 Global Biologics and Biosimilars Sales and Market Share by Player (2016-2018)
    2.2 Global Biologics and Biosimilars Revenue and Market Share by Player (2016-2018)
    2.3 Global Biologics and Biosimilars Average Price by Player (2016-2018)
    2.4 Players Competition Situation & Trends
    2.5 Conclusion of Segment by Player

Chapter 3 Biologics and Biosimilars Market Segment Analysis by Type
    3.1 Global Biologics and Biosimilars Market by Type
        3.1.1 Monoclonal Antibodies
        3.1.2 Interferon
        3.1.3 Erythropoietin
        3.1.4 Insulin
        3.1.5 Vaccines
    3.2 Global Biologics and Biosimilars Sales and Market Share by Type (2013-2018)
    3.3 Global Biologics and Biosimilars Revenue and Market Share by Type (2013-2018)
    3.4 Global Biologics and Biosimilars Average Price by Type (2013-2018)
    3.5 Leading Players of Biologics and Biosimilars by Type in 2018
    3.6 Conclusion of Segment by Type

Chapter 4 Biologics and Biosimilars Market Segment Analysis by Application
    4.1 Global Biologics and Biosimilars Market by Application
        4.1.1 Tumor
        4.1.2 Diabetes
        4.1.3 Cardiovascular
        4.1.4 Hemophilia
        4.1.5 Other
    4.2 Global Biologics and Biosimilars Sales and Market Share by Application (2013-2018)
    4.3 Leading Consumers of Biologics and Biosimilars by Application in 2018
    4.4 Conclusion of Segment by Application

Chapter 5 Biologics and Biosimilars Market Segment Analysis by Sales Channel
    5.1 Global Biologics and Biosimilars Market by Sales Channel
        5.1.1 Direct Channel
        5.1.2 Distribution Channel
    5.2 Global Biologics and Biosimilars Sales and Market Share by Sales Channel (2013-2018)
    5.3 Leading Distributors/Dealers of Biologics and Biosimilars by Sales Channel in 2018
    5.4 Conclusion of Segment by Sales Channel

Chapter 6 Biologics and Biosimilars Market Segment Analysis by Region
    6.1 Global Biologics and Biosimilars Market Size and CAGR by Region (2013-2028)
    6.2 Global Biologics and Biosimilars Sales and Market Share by Region (2013-2018)
    6.3 Global Biologics and Biosimilars Revenue and Market Share by Region (2013-2018)
    6.4 North America
        6.4.1 North America Market by Country
        6.4.2 North America Biologics and Biosimilars Market Share by Type
        6.4.3 North America Biologics and Biosimilars Market Share by Application
        6.4.4 United States
        6.4.5 Canada
        6.4.6 Mexico
    6.5 Europe
        6.5.1 Europe Market by Country
        6.5.2 Europe Biologics and Biosimilars Market Share by Type
        6.5.3 Europe Biologics and Biosimilars Market Share by Application
        6.5.4 Germany
        6.5.5 UK
        6.5.6 France
        6.5.7 Italy
        6.5.8 Russia
        6.5.9 Spain
    6.6 Asia-Pacific
        6.6.1 Asia-Pacific Market by Country
        6.6.2 Asia-Pacific Biologics and Biosimilars Market Share by Type
        6.6.3 Asia-Pacific Biologics and Biosimilars Market Share by Application
        6.6.4 China
        6.6.5 Japan
        6.6.6 Korea
        6.6.7 India
        6.6.8 Southeast Asia
        6.6.9 Australia
    6.7 South America
        6.7.1 South America Market by Country
        6.7.2 South America Biologics and Biosimilars Market Share by Type
        6.7.3 South America Biologics and Biosimilars Market Share by Application
        6.7.4 Brazil
        6.7.5 Argentina
        6.7.6 Colombia
        6.7.7 Chile
    6.8 Middle East & Africa
        6.8.1 Middle East & Africa Market by Country
        6.8.2 Middle East & Africa Biologics and Biosimilars Market Share by Type
        6.8.3 Middle East & Africa Biologics and Biosimilars Market Share by Application
        6.8.4 Egypt
        6.8.5 Saudi Arabia
        6.8.6 South Africa
        6.8.7 Nigeria
    6.9 Conclusion of Segment by Region

Chapter 7 Profile of Leading Biologics and Biosimilars Players
    7.1 Roche
        7.1.1 Company Snapshot
        7.1.2 Product/Business Offered
        7.1.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)
        7.1.4 Strategy and SWOT Analysis
    7.2 Amgen
    7.3 AbbVie
    7.4 Sanofi-Aventis
    7.5 Johnson & Johnson
    7.6 Pfizer
    7.7 Novo Nordisk
    7.8 Eli Lilly
    7.9 Novartis
    7.10 Merck
    7.11 3sbio
    7.12 Changchun High Tech
    7.13 CP Guojian
    7.14 Biotech
    7.15 Gelgen
    7.16 Innovent
    7.17 Dong Bao
    7.18 Ganlee

Chapter 8 Upstream and Downstream Analysis of Biologics and Biosimilars
    8.1 Industrial Chain of Biologics and Biosimilars
    8.2 Upstream of Biologics and Biosimilars
        8.2.1 Raw Materials
        8.2.2 Labor Cost
        8.2.3 Manufacturing Expenses
        8.2.4 Manufacturing Cost Structure
        8.2.5 Manufacturing Process
    8.3 Downstream of Biologics and Biosimilars
        8.3.1 Leading Distributors/Dealers of Biologics and Biosimilars
        8.3.2 Leading Consumers of Biologics and Biosimilars

Chapter 9 Development Trend of Biologics and Biosimilars (2019-2028)
    9.1 Global Biologics and Biosimilars Market Size (Sales and Revenue) Forecast (2019-2028)
    9.2 Global Biologics and Biosimilars Market Size and CAGR Forecast by Region (2019-2028)
    9.3 Global Biologics and Biosimilars Market Size and CAGR Forecast by Type (2019-2028)
    9.4 Global Biologics and Biosimilars Market Size and CAGR Forecast by Application (2019-2028)
    9.5 Global Biologics and Biosimilars Market Size Forecast by Sales Channel (2019-2028)

Chapter 10 Appendix
    10.1 Research Methodology
    10.2 Data Sources
    10.3 Disclaimer
    10.4 Analysts Certification

List of Tables and Figures

    Figure Biologics and Biosimilars Example
    Figure Global Biologics and Biosimilars Revenue (Million $) Status and Outlook (2013-2028)
    Figure Global Biologics and Biosimilars Revenue (Million $) Comparison by Region (2013-2028)
    Figure Global Biologics and Biosimilars Sales Comparison by Type (2013-2028)
    Figure Global Biologics and Biosimilars Sales Comparison by Application (2013-2028)
    Figure Global Biologics and Biosimilars Sales Comparison by Sales Channel (2013-2028)
    Table Global Biologics and Biosimilars Sales by Player (2016-2018)
    Table Global Biologics and Biosimilars Sales Market Share by Player (2016-2018)
    Figure Global Biologics and Biosimilars Sales Market Share by Player in 2018
    Table Global Biologics and Biosimilars Revenue (Million $) by Player (2016-2018)
    Table Global Biologics and Biosimilars Revenue Market Share by Player (2016-2018)
    Figure Global Biologics and Biosimilars Revenue Market Share by Player in 2018
    Table Global Biologics and Biosimilars Average Price by Player (2016-2018)
    Figure Global Biologics and Biosimilars Average Price by Player in 2018
    Figure Global Biologics and Biosimilars Players Competition Situation - Top 5 Players' Revenue Market Share in 2016
    Figure Global Biologics and Biosimilars Players Competition Trends - Top 5 Players' Revenue Market Share in 2018
    Figure Example of Monoclonal Antibodies
    Figure Global Monoclonal Antibodies Sales and Growth Rate (2013-2018)
    Figure Example of Interferon
    Figure Global Interferon Sales and Growth Rate (2013-2018)
    Figure Example of Erythropoietin
    Figure Global Erythropoietin Sales and Growth Rate (2013-2018)
    Figure Example of Insulin
    Figure Global Insulin Sales and Growth Rate (2013-2018)
    Figure Example of Vaccines
    Figure Global Vaccines Sales and Growth Rate (2013-2018)
    Table Global Biologics and Biosimilars Sales by Type (2013-2018)
    Table Global Biologics and Biosimilars Sales Market Share by Type (2013-2018)
    Figure Global Biologics and Biosimilars Sales Market Share by Type in 2018
    Table Global Biologics and Biosimilars Revenue (Million $) by Type (2013-2018)
    Table Global Biologics and Biosimilars Revenue Market Share by Type (2013-2018)
    Figure Global Biologics and Biosimilars Revenue Market Share by Type in 2018
    Table Global Biologics and Biosimilars Average Price by Type (2013-2018)
    Figure Global Biologics and Biosimilars Average Price by Type in 2018
    Table Leading Players of Biologics and Biosimilars by Type in 2018
    Figure Example of Tumor
    Figure Global Biologics and Biosimilars for Tumor Sales and Growth Rate (2013-2018)
    Figure Example of Diabetes
    Figure Global Biologics and Biosimilars for Diabetes Sales and Growth Rate (2013-2018)
    Figure Example of Cardiovascular
    Figure Global Biologics and Biosimilars for Cardiovascular Sales and Growth Rate (2013-2018)
    Figure Example of Hemophilia
    Figure Global Biologics and Biosimilars for Hemophilia Sales and Growth Rate (2013-2018)
    Figure Example of Other
    Figure Global Biologics and Biosimilars for Other Sales and Growth Rate (2013-2018)
    Table Global Biologics and Biosimilars Sales by Application (2013-2018)
    Table Global Biologics and Biosimilars Sales Market Share by Application (2013-2018)
    Figure Global Biologics and Biosimilars Sales Market Share by Application in 2018
    Table Leading Consumers of Biologics and Biosimilars by Application in 2018
    Figure Example of Direct Channel
    Figure Global Biologics and Biosimilars for Direct Channel Sales and Growth Rate (2013-2018)
    Figure Example of Distribution Channel
    Figure Global Biologics and Biosimilars for Distribution Channel Sales and Growth Rate (2013-2018)
    Table Global Biologics and Biosimilars Sales by Sales Channel (2013-2018)
    Table Global Biologics and Biosimilars Sales Market Share by Sales Channel (2013-2018)
    Figure Global Biologics and Biosimilars Sales Market Share by Sales Channel in 2018
    Table Leading Distributors/Dealers of Biologics and Biosimilars by Sales Channel in 2018
    Table Global Biologics and Biosimilars Market Size and CAGR by Region (2013-2028)
    Table Global Biologics and Biosimilars Sales by Region (2013-2018)
    Table Global Biologics and Biosimilars Sales Market Share by Region (2013-2018)
    Figure Global Biologics and Biosimilars Sales Market Share by Region in 2018
    Table Global Biologics and Biosimilars Revenue (Million $) by Region (2013-2018)
    Table Global Biologics and Biosimilars Revenue Market Share by Region (2013-2018)
    Figure Global Biologics and Biosimilars Revenue Market Share by Region in 2018
    Table North America Biologics and Biosimilars Sales by Country (2013-2018)
    Figure North America Biologics and Biosimilars Sales Market Share by Country (2013-2018)
    Table North America Biologics and Biosimilars Revenue by Country (2013-2018)
    Figure North America Biologics and Biosimilars Revenue Market Share by Country (2013-2018)
    Figure North America Biologics and Biosimilars Sales Market Share by Type in 2018
    Figure North America Biologics and Biosimilars Sales Market Share by Application in 2018
    Figure United States Biologics and Biosimilars Sales and Growth Rate (2013-2018)
    Figure United States Biologics and Biosimilars Revenue (Million $) and Growth Rate (2013-2018)
    Figure Canada Biologics and Biosimilars Sales and Growth Rate (2013-2018)
    Figure Canada Biologics and Biosimilars Revenue (Million $) and Growth Rate (2013-2018)
    Figure Mexico Biologics and Biosimilars Sales and Growth Rate (2013-2018)
    Figure Mexico Biologics and Biosimilars Revenue (Million $) and Growth Rate (2013-2018)
    Table Europe Biologics and Biosimilars Sales by Country (2013-2018)
    Figure Europe Biologics and Biosimilars Sales Market Share by Country (2013-2018)
    Table Europe Biologics and Biosimilars Revenue by Country (2013-2018)
    Figure Europe Biologics and Biosimilars Revenue Market Share by Country (2013-2018)
    Figure Europe Biologics and Biosimilars Sales Market Share by Type in 2018
    Figure Europe Biologics and Biosimilars Sales Market Share by Application in 2018
    Figure Germany Biologics and Biosimilars Sales and Growth Rate (2013-2018)
    Figure Germany Biologics and Biosimilars Revenue (Million $) and Growth Rate (2013-2018)
    Figure UK Biologics and Biosimilars Sales and Growth Rate (2013-2018)
    Figure UK Biologics and Biosimilars Revenue (Million $) and Growth Rate (2013-2018)
    Figure France Biologics and Biosimilars Sales and Growth Rate (2013-2018)
    Figure France Biologics and Biosimilars Revenue (Million $) and Growth Rate (2013-2018)
    Figure Italy Biologics and Biosimilars Sales and Growth Rate (2013-2018)
    Figure Italy Biologics and Biosimilars Revenue (Million $) and Growth Rate (2013-2018)
    Figure Russia Biologics and Biosimilars Sales and Growth Rate (2013-2018)
    Figure Russia Biologics and Biosimilars Revenue (Million $) and Growth Rate (2013-2018)
    Figure Spain Biologics and Biosimilars Sales and Growth Rate (2013-2018)
    Figure Spain Biologics and Biosimilars Revenue (Million $) and Growth Rate (2013-2018)
    Table Asia-Pacific Biologics and Biosimilars Sales by Country (2013-2018)
    Figure Asia-Pacific Biologics and Biosimilars Sales Market Share by Country (2013-2018)
    Table Asia-Pacific Biologics and Biosimilars Revenue by Country (2013-2018)
    Figure Asia-Pacific Biologics and Biosimilars Revenue Market Share by Country (2013-2018)
    Figure Asia-Pacific Biologics and Biosimilars Sales Market Share by Type in 2018
    Figure Asia-Pacific Biologics and Biosimilars Sales Market Share by Application in 2018
    Figure China Biologics and Biosimilars Sales and Growth Rate (2013-2018)
    Figure China Biologics and Biosimilars Revenue (Million $) and Growth Rate (2013-2018)
    Figure Japan Biologics and Biosimilars Sales and Growth Rate (2013-2018)
    Figure Japan Biologics and Biosimilars Revenue (Million $) and Growth Rate (2013-2018)
    Figure Korea Biologics and Biosimilars Sales and Growth Rate (2013-2018)
    Figure Korea Biologics and Biosimilars Revenue (Million $) and Growth Rate (2013-2018)
    Figure India Biologics and Biosimilars Sales and Growth Rate (2013-2018)
    Figure India Biologics and Biosimilars Revenue (Million $) and Growth Rate (2013-2018)
    Figure Southeast Asia Biologics and Biosimilars Sales and Growth Rate (2013-2018)
    Figure Southeast Asia Biologics and Biosimilars Revenue (Million $) and Growth Rate (2013-2018)
    Figure Australia Biologics and Biosimilars Sales and Growth Rate (2013-2018)
    Figure Australia Biologics and Biosimilars Revenue (Million $) and Growth Rate (2013-2018)
    Table South America Biologics and Biosimilars Sales by Country (2013-2018)
    Figure South America Biologics and Biosimilars Sales Market Share by Country (2013-2018)
    Table South America Biologics and Biosimilars Revenue by Country (2013-2018)
    Figure South America Biologics and Biosimilars Revenue Market Share by Country (2013-2018)
    Figure South America Biologics and Biosimilars Sales Market Share by Type in 2018
    Figure South America Biologics and Biosimilars Sales Market Share by Application in 2018
    Figure Brazil Biologics and Biosimilars Sales and Growth Rate (2013-2018)
    Figure Brazil Biologics and Biosimilars Revenue (Million $) and Growth Rate (2013-2018)
    Figure Argentina Biologics and Biosimilars Sales and Growth Rate (2013-2018)
    Figure Argentina Biologics and Biosimilars Revenue (Million $) and Growth Rate (2013-2018)
    Figure Colombia Biologics and Biosimilars Sales and Growth Rate (2013-2018)
    Figure Colombia Biologics and Biosimilars Revenue (Million $) and Growth Rate (2013-2018)
    Figure Chile Biologics and Biosimilars Sales and Growth Rate (2013-2018)
    Figure Chile Biologics and Biosimilars Revenue (Million $) and Growth Rate (2013-2018)
    Table Middle East & Africa Biologics and Biosimilars Sales by Country (2013-2018)
    Figure Middle East & Africa Biologics and Biosimilars Sales Market Share by Country (2013-2018)
    Table Middle East & Africa Biologics and Biosimilars Revenue by Country (2013-2018)
    Figure Middle East & Africa Biologics and Biosimilars Revenue Market Share by Country (2013-2018)
    Figure Middle East & Africa Biologics and Biosimilars Sales Market Share by Type in 2018
    Figure Middle East & Africa Biologics and Biosimilars Sales Market Share by Application in 2018
    Figure Egypt Biologics and Biosimilars Sales and Growth Rate (2013-2018)
    Figure Egypt Biologics and Biosimilars Revenue (Million $) and Growth Rate (2013-2018)
    Figure Saudi Arabia Biologics and Biosimilars Sales and Growth Rate (2013-2018)
    Figure Saudi Arabia Biologics and Biosimilars Revenue (Million $) and Growth Rate (2013-2018)
    Figure South Africa Biologics and Biosimilars Sales and Growth Rate (2013-2018)
    Figure South Africa Biologics and Biosimilars Revenue (Million $) and Growth Rate (2013-2018)
    Figure Nigeria Biologics and Biosimilars Sales and Growth Rate (2013-2018)
    Figure Nigeria Biologics and Biosimilars Revenue (Million $) and Growth Rate (2013-2018)
    Table Company Snapshot of Roche
    Table Biologics and Biosimilars Introduction of Roche
    Table Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share of Roche (2016-2018)
    Table Industrial Chain of Biologics and Biosimilars
    Table Manufacturing Cost Structure of Biologics and Biosimilars
    Table General Manufacturing Process of Biologics and Biosimilars
    Table Leading Distributors/Dealers of Biologics and Biosimilars
    Table Leading Consumers of Biologics and Biosimilars
    Figure Global Biologics and Biosimilars Sales and Growth Rate Forecast (2019-2028)
    Figure Global Biologics and Biosimilars Revenue and Growth Rate Forecast (2019-2028)
    Table Global Biologics and Biosimilars Market Size and CAGR Forecast by Region (2019-2028)
    Table Global Biologics and Biosimilars Market Size and CAGR Forecast by Type (2019-2028)
    Table Global Biologics and Biosimilars Market Size and CAGR Forecast by Application (2019-2028)
    Table Global Biologics and Biosimilars Market Size and CAGR Forecast by Sales Channel (2019-2028)

To request a free sample copy of this report, please complete the form below.

Interested in this report? Get your FREE sample now! Get a Free Sample

Did you know?

Our library has over 100000 reports on 1000s of topics

Over 100+ Fortune 500 companies rely on us

90,000+ people come to us for insights every month

Research Assistance

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Why to buy from us

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Information security

Your personal and confidential information is safe and secure.